Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 5/20 | 0.75 |
| ▸ | NCOA3 | Q9Y6Q9 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | TLR4 | O00206 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | TYMS | P04818 | 1/20 | 0.75 |
| ▸ | GLA | P06280 | 1/20 | 0.75 |
| ▸ | POLB | P06746 | 1/20 | 0.75 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | FOLR2 | P14207 | 1/20 | 0.75 |
| ▸ | FOLR1 | P15328 | 1/20 | 0.75 |
| ▸ | HPGD | P15428 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.75 |
| ▸ | GART | P22102 | 1/20 | 0.75 |
| ▸ | APEX1 | P27695 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10653854 | 1.00 | DHFR (0.75) | DHFRNCOA3KDM4ETLR4MEN1 | |
| SCHEMBL31237427 | 0.95 | DHFR (0.70) | DHFRNCOA3KDM4ETLR4MEN1 | |
| SCHEMBL26422291 | 0.94 | DHFR (0.67) | DHFRNCOA3KDM4ETLR4MEN1 | |
| SCHEMBL5325480 | 0.92 | DHFR (0.77) | DHFRNCOA3KDM4ETLR4MEN1 | |
| SCHEMBL20228929 | 0.92 | DHFR (0.77) | DHFRNCOA3KDM4ETLR4MEN1 | |
| SCHEMBL20228932 | 0.87 | FPGS (0.75) | DHFRNCOA3KDM4ETLR4MEN1 | |
| SCHEMBL26422313 | 0.86 | DHFR (0.69) | DHFRNCOA3KDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL171251 | 0.86 | DHFR (1.00) | DHFRNCOA3KDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL3711 | 0.86 | DHFR (1.00) | DHFRNCOA3KDM4ETLR4MEN1 | |
| Methotrexate SCHEMBL20548444 | 0.86 | DHFR (1.00) | DHFRNCOA3KDM4ETLR4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3382 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091124-A1 | CLICK-TO-RELEASE ON PROTEINS AND PEPTIDES | VALANX BIOTECH GMBH (AT) | 2026-04-02 | — | — | US | claimed |
| EP-4701667-A1 | TROP2 BINDERS AND CONJUGATES THEREOF | Merck Sharp & Dohme LLC (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4603107-A1 | BIOORTHOGONAL, ANILINIUM BASED CLEAVABLE TETRAZINES | University of Copenhagen (DK) | 2025-08-20 | — | — | EP | claimed |
| EP-4590342-A1 | CLICK-TO-RELEASE ON PROTEINS AND PEPTIDES | VALANX Biotech GmbH (AT) | 2025-07-30 | — | — | EP | claimed |
| WO-2025122699-A1 | CDC7 INHIBITOR COMBINATIONAL THERAPY | Lin Bioscience, Inc. (TW) | 2025-06-12 | — | — | WO | claimed |
| US-20250172563-A1 | MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2025-05-29 | — | — | US | claimed |
| US-20250090495-A1 | CDC7 Inhibitor Combinational Therapy | Lin Bioscience, Inc. (TW) | 2025-03-20 | — | — | US | claimed |
| WO-2024226410-A1 | TROP2 BINDERS AND CONJUGATES THEREOF | MERCK SHARP & DOHME LLC (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4382167-A2 | COMPOUNDS COMPRISING A LINKER FOR INCREASING TRANSCYCLOOCTENE STABILITY | Tagworks Pharmaceuticals B.V. (NL) | 2024-06-12 | — | — | EP | claimed |
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | COBIORES NV (BE) | 2024-04-18 | — | — | US | claimed |
| EP-1144011-A2 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | Coulter Pharmaceutical, Inc. (US) | 2001-10-17 | — | — | EP | claimed |
| EP-1135410-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | Cyclacel Limited (GB) | 2001-09-26 | — | — | EP | claimed |
| WO-2000033888-A9 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COULTER PHARM INC (US) | 2001-05-10 | — | — | WO | claimed |
| EP-1093383-A1 | DRUG DELIVERY SYSTEM COMPRISING A HOMEOBOX PEPTIDE | Cyclacel Limited (GB) | 2001-04-25 | — | — | EP | claimed |
| WO-2000033888-A2 | PRODRUG COMPOUNDS AND PROCESS FOR PREPARATION THEREOF | COULTER PHARMACEUTICAL, INC. (US) | 2000-06-15 | — | — | WO | claimed |
| WO-2000029427-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | CYCLACEL LIMITED (GB) | 2000-05-25 | — | — | WO | claimed |
| CN-1242708-A | Conjugates for the treatment of prostate cancer | MERCK & CO INC (US) | 2000-01-26 | — | — | CN | claimed |
| WO-2000001417-A1 | DELIVERY SYSTEM | CYCLACEL LIMITED (GB) | 2000-01-13 | — | — | WO | claimed |
| EP-0359347-B1 | COVALENTLY-LINKED COMPLEXES AND METHODS FOR ENHANCED CYTOTOXICITY AND IMAGING | NEORX CORPORATION (US) | 1992-12-23 | — | — | EP | claimed |
| EP-0359347-A2 | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging | NEORX CORPORATION (US) | 1990-03-21 | — | — | EP | claimed |